University Hospital and New Jersey Medical School (NJMS) are, through their joint FDA-approved convalescent plasma program, collecting plasma donations from patients who have recovered from COVID-19 and infusing it into patients still struggling to fight off the virus. Marc Klapholz, chair of NJMS” Department of Medicine and the hospital’s chief of medical service, explains that the presumed antibodies in the plasma may improve seriously ill patients’ chances for survival. To read the full article.
Recent Posts
- New NJACTS Publication
- Study Finds Transfusing More Blood Reduces Risk of Death at Six Months in Heart-Attack Patients with Anemia.
- New NJACTS Publication
- Princeton researchers awarded NJ ACTS grant to study dendritic plasticity in neuropsychiatric disorders.
- Exercise Improves Brain Function, Possibly Reducing Dementia Risk.
Categories
- Community (2,128)
- Covid (981)
- CTO Events (6)
- News (2,715)
- Pilots (21)